WRF
VRTX icon

Waddell & Reed Financial’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$300M Buy
1,396,827
+10
+0% +$2.15K 0.62% 33
2020
Q4
$330M Sell
1,396,817
-343,440
-20% -$81.2M 0.7% 28
2020
Q3
$474M Sell
1,740,257
-18,171
-1% -$4.94M 1.14% 9
2020
Q2
$510M Sell
1,758,428
-304,949
-15% -$88.5M 1.32% 7
2020
Q1
$491M Sell
2,063,377
-243,878
-11% -$58M 1.6% 7
2019
Q4
$505M Buy
2,307,255
+67,781
+3% +$14.8M 1.25% 8
2019
Q3
$379M Buy
2,239,474
+4,829
+0.2% +$818K 0.98% 19
2019
Q2
$410M Buy
2,234,645
+133,930
+6% +$24.6M 1.01% 17
2019
Q1
$386M Sell
2,100,715
-70,342
-3% -$12.9M 0.96% 17
2018
Q4
$360M Sell
2,171,057
-37,421
-2% -$6.2M 1.02% 14
2018
Q3
$426M Sell
2,208,478
-19,877
-0.9% -$3.83M 0.94% 18
2018
Q2
$379M Sell
2,228,355
-132,591
-6% -$22.5M 0.88% 22
2018
Q1
$385M Sell
2,360,946
-497,901
-17% -$81.1M 0.87% 22
2017
Q4
$428M Sell
2,858,847
-741,394
-21% -$111M 0.95% 18
2017
Q3
$547M Sell
3,600,241
-426,182
-11% -$64.8M 1.22% 13
2017
Q2
$519M Buy
4,026,423
+392,420
+11% +$50.6M 1.14% 15
2017
Q1
$397M Sell
3,634,003
-214,602
-6% -$23.5M 0.84% 25
2016
Q4
$284M Sell
3,848,605
-193,243
-5% -$14.2M 0.62% 41
2016
Q3
$352M Sell
4,041,848
-216,630
-5% -$18.9M 0.73% 32
2016
Q2
$366M Sell
4,258,478
-303,165
-7% -$26.1M 0.77% 31
2016
Q1
$363M Sell
4,561,643
-426,120
-9% -$33.9M 0.68% 36
2015
Q4
$628M Buy
4,987,763
+36,873
+0.7% +$4.64M 1.02% 21
2015
Q3
$516M Buy
4,950,890
+215,016
+5% +$22.4M 0.85% 28
2015
Q2
$585M Buy
4,735,874
+518,486
+12% +$64M 0.84% 32
2015
Q1
$498M Buy
4,217,388
+385,088
+10% +$45.4M 0.69% 41
2014
Q4
$455M Sell
3,832,300
-4,700
-0.1% -$558K 0.63% 46
2014
Q3
$431M Buy
3,837,000
+28,200
+0.7% +$3.17M 0.6% 55
2014
Q2
$361M Buy
3,808,800
+199,800
+6% +$18.9M 0.53% 63
2014
Q1
$255M Buy
3,609,000
+43,300
+1% +$3.06M 0.39% 74
2013
Q4
$265M Buy
3,565,700
+387,100
+12% +$28.8M 0.43% 69
2013
Q3
$241M Buy
3,178,600
+267,500
+9% +$20.3M 0.46% 61
2013
Q2
$233M Buy
+2,911,100
New +$233M 0.49% 57